Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02415153Phase 1Completed
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Neurofibromatosis Type 1Recurrent Childhood Brain Stem GliomaRecurrent Childhood Visual Pathway Glioma+2 more
PrincipalinvestigatorStart date: 2015-07-14
NCT01089101Phase 1/2Active Not Recruiting
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Neurofibromatosis Type 1+3 more
PrincipalinvestigatorStart date: 2010-07-07

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

M. Sue O'Dorisio, MD, PhD

University of Iowa

Related
4 trials

Shared therapeutic areas:

Recurrent Childhood Brain Stem GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Childhood Visual Pathway Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Margot Lazow, MD

Nationwide Children's Hospital

Related
4 trials

Shared therapeutic areas:

Recurrent Primary Central Nervous System NeoplasmRefractory Primary Central Nervous System Neoplasm
Similarity Score5%

AeRang Kim, MD, PhD

Children's National Research Institute

Related
7 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score3%

Jing Wu, M.D.

National Cancer Institute (NCI)

Related
5 trials

Shared therapeutic areas:

Low Grade Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Recurrent Childhood Brain Stem Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Amar Gajjar

Pediatric Brain Tumor Consortium

Related
4 trials

Shared therapeutic areas:

Recurrent Childhood Brain Stem Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Roger J. Packer, MD

Children's National Research Institute

Related
5 trials

Shared therapeutic areas:

Neurofibromatosis 1

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Eric Bouffet, MD

The Hospital for Sick Children

Related
3 trials

Shared therapeutic areas:

Low Grade Glioma
Similarity Score3%

Vanessa Merker, PhD

Massachusetts General Hospital

Related
3 trials

Shared therapeutic areas:

Neurofibromatosis 1
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02415153Phase 1PrincipalInvestigator

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Neurofibromatosis Type 1Recurrent Childhood Brain Stem GliomaRecurrent Childhood Visual Pathway Glioma+2 more
Completed
NCT01089101Phase 1/2PrincipalInvestigator

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Low Grade GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Neurofibromatosis Type 1+3 more
Active Not Recruiting

All 2 trials loaded